180 Life Sciences (ATNF)
(Delayed Data from NSDQ)
$3.54 USD
+0.26 (7.93%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $3.37 -0.17 (-4.80%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ATNF 3.54 +0.26(7.93%)
Will ATNF be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ATNF based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for ATNF
EXCLUSIVE: July's 20 Most-Searched Tickers On Benzinga Pro — Where Do Opendoor, Nvidia, Apple Stock Rank?
180 Life Sciences (ATNF) Announces $425M PIPE Deal for Ethereum Focus
Another Ethereum Treasury Play: 180 Life Sciences Raises $425 Million To Buy ETH
180 Life Sciences to raise $425M, rebrand as ETHZilla to launch Ethereum treasury strategy
180 Life Sciences (ATNF) to Transition into ETHZilla with New Treasury Strategy